Immunome Inc. (IMNM) — Operating Income
| Fiscal Year | Operating Income | Change YoY |
|---|---|---|
| 2025 | -$224.11M | +26.7% |
| 2024 | -$305.80M | -179.2% |
| 2023 | -$109.53M | -196.8% |
| 2022 | -$36.90M | -46.4% |
| 2021 | -$25.20M | -105.6% |
| 2020 | -$12.26M | -18.5% |
| 2019 | -$10.35M | — |
| Fiscal Year | Operating Income | Change YoY |
|---|---|---|
| 2025 | -$224.11M | +26.7% |
| 2024 | -$305.80M | -179.2% |
| 2023 | -$109.53M | -196.8% |
| 2022 | -$36.90M | -46.4% |
| 2021 | -$25.20M | -105.6% |
| 2020 | -$12.26M | -18.5% |
| 2019 | -$10.35M | — |